The University of Texas Health Science Center at Houston (UTHealth) announced yesterday that it has received an $11 million grant from the National Institute of Allergy and Infectious Diseases to conduct a 5-year study to better understand why some critically ill patients develop multidrug-resistant infections.
World Health Organization (WHO) flu vaccine advisors recently met to recommend the strains to include in vaccines for the Southern Hemisphere's 2021 season, which—when compared with the Northern Hemisphere upcoming-season version—swaps out the 2009 H1N1 strain.
A phase 3 trial for a bivalent Clostridioides difficile toxoid vaccine was terminated because of futility, an international team of investigators led by scientists from Sanofi Pasteur reported yesterday in The Lancet Infectious Diseases.
Living with a family member with C difficile increased the risk of contracting the disease 12-fold.
A study by researchers from Detroit Medical Center and Wayne State University highlights the risk of Clostridiodes difficile infection (CDI) among COVID-19 patients linked to antibiotic use. The findings appeared in Emerging Infectious Diseases.
CARB-X today announced an award of up to $1.26 million to Facile Therapeutics of Belmont, California, to develop a new oral drug for recurrent Clostridioides difficile infections.
A low-intensity, multifaceted stewardship intervention implemented at nursing homes was associated with improved antibiotic prescribing for urinary tract infections (UTIs), US researchers reported today in JAMA Internal Medicine.
The Democratic Republic of Congo (DRC) reported one more Ebola infection, raising the number of recent cases in Beni to seven.
The patient is a 39-year-old woman who had been in isolation since her daughter died from Ebola on April 20, Reuters reported yesterday. Her illness raises the outbreak total to 3,462, including 2,267 deaths, according to the World Health Organization (WHO) online dashboard.
Applying diagnostic stewardship to molecular testing for Clostridioides difficile infection (CDI) at a hospital system in California was associated with to a significant reduction in testing, cases, and costs, researchers reported today in Infection Control and Hospital Epidemiology.
The findings suggest that prevention efforts, particularly in hospitals, are yielding benefits.